SCHEMBL10746479

SCHEMBL10746479

S=c1c2ccccc2[se]n1-c1ccc2[nH]ncc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 7/20 0.44
▸ GSK3B P49841 5/20 0.44
▸ JAK2 O60674 4/20 0.44
▸ AURKB Q96GD4 3/20 0.44
▸ CDK5 Q00535 2/20 0.44
▸ DYRK1A Q13627 2/20 0.44
▸ CDK2 P24941 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ ROCK1 Q13464 2/20 0.44
▸ CDC7 O00311 2/20 0.44
▸ AURKA O14965 1/20 0.44
▸ CHUK O15111 1/20 0.44
▸ DAPK3 O43293 1/20 0.44
▸ CHEK2 O96017 1/20 0.44
▸ CDK1 P06493 1/20 0.44
▸ PIM1 P11309 1/20 0.44
▸ PRKACA P17612 1/20 0.44
▸ MARK3 P27448 1/20 0.44
▸ CSNK1D P48730 1/20 0.44
▸ GSK3A P49840 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916818 0.84 METAP2 (0.54) CYP2D6IDO1METAP2KDM4EMEN1
SCHEMBL10746714 0.80 NPC1 (0.41) CYP2D6SLC6A2SLC6A4SLC6A3TRPA1
SCHEMBL10749814 0.78 METAP2 (0.34) CYP2D6IDO1METAP2KDM4EMEN1
SCHEMBL10746418 0.75 METAP2 (0.40) CYP2D6IDO1METAP2KDM4EMEN1
SCHEMBL10746610 0.75 MAPK1 (0.43) CDK5CDK2MAPK1ROCK1AURKA
SCHEMBL5916663 0.74 METAP2 (0.54) CYP2D6IDO1METAP2KDM4EMEN1
SCHEMBL10501187 0.72 METAP2 (0.45) CYP2D6IDO1METAP2KDM4EMEN1
SCHEMBL10501589 0.71 METAP2 (0.61) CYP2D6IDO1METAP2KDM4EMEN1
SCHEMBL10749752 0.71 CYP11B1 (0.43) CYP2D6IDO1METAP2KDM4EMEN1
SCHEMBL10502470 0.69 METAP2 (0.46) CYP2D6IDO1HSP90AA1METAP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback